DaShenLin Pharmaceutical Group Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 21,248.09 million compared to CNY 16,759.34 million a year ago. Revenue was CNY 21,248.09 million compared to CNY 16,759.34 million a year ago.

Net income was CNY 1,035.72 million compared to CNY 791.23 million a year ago. Basic earnings per share from continuing operations was CNY 0.9083 compared to CNY 0.7 a year ago. Diluted earnings per share from continuing operations was CNY 0.9083 compared to CNY 0.7 a year ago.